脑动极光医疗科技有限公司（06681）于2026年2月5日发布翌日披露报表，公告显示公司已向认购方配发及发行92,000,000股新股份，配售价为每股港币5.6。该批新股占发行前已发行股本的约7.27%。
本次股份发行完成后，公司已发行股本从1,266,278,000股增至1,358,278,000股，库藏股份数保持为零。公司声明，本次发行已获董事会正式授权，并已遵循所有适用的上市规则及法律法规。公告由董事谭錚签署。
脑动极光医疗科技有限公司（06681）于2026年2月5日发布翌日披露报表，公告显示公司已向认购方配发及发行92,000,000股新股份，配售价为每股港币5.6。该批新股占发行前已发行股本的约7.27%。
本次股份发行完成后，公司已发行股本从1,266,278,000股增至1,358,278,000股，库藏股份数保持为零。公司声明，本次发行已获董事会正式授权，并已遵循所有适用的上市规则及法律法规。公告由董事谭錚签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.